T1	Participants 222 250	patients with schizophrenia.
T2	Participants 390 449	individual patient with schizophrenia receiving medication.
T3	Participants 1086 1114	healthcare setting in Japan.
T4	Participants 1297 1490	patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability.
T5	Participants 1718 1763	The target number of subjects was set at 300.
T6	Participants 1918 1945	patients with schizophrenia
T7	Participants 1964 2059	highly valuable to perform this effectiveness study under ordinary healthcare setting in Japan.
